MAPT and Alzheimer disease: It is worth noting that the accumulation of tau in AD may impede proteasome function, potentially leading to the pathological promotion of MAPS-mediated tau secretion as a compensatory mechanism for impaired PQC, thereby reducing the intracellular levels of misfolded tau [161,162,163].